| MR编号 | UK/H/6866/002 | ||||||
|---|---|---|---|---|---|---|---|
| 药品名称 | Clobazam 10 mg/ 5 ml Oral Suspension | ||||||
| 活性成分 |
| ||||||
| 剂型 | Oral suspension | ||||||
| 上市许可持有人 | Teva Pharmaceuticals Europe B.V. [C/O Teva UK Ltd,] Field House Station Approach Harlow Essex CM20 2FB United Kingdom | ||||||
| 参考成员国 - 产品名称 | United Kingdom (GB) | ||||||
| 互认成员国 - 产品名称 |
| ||||||
| 许可日期 | 2018/12/17 | ||||||
| 最近更新日期 | 2019/08/28 | ||||||
| 药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn（注：已撤市） | 撤市原因：2.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided could allow to conclude on a positive benefit-risk balance if the points for clarification identified were solved. |